Page 341 - Vitamin D and Cancer
P. 341

328                                                       B.W. Hollis

            15.1   Introduction


            In 1971, Haddad and Chyu published a seminal paper in The Journal of Clinical
            Endocrinology and Metabolism that described a competitive protein-binding assay
            (CPBA)  for  the  determination  of  circulating  25-hydroxycalfierol  [25(OH)D]  in
            human subjects [1]. In this paper they also presented limited patient data for defini-
            tion of “normal” circulating 25(OH)D levels in humans (Table 15.1). Their “nor-
            mal” subjects were basically asymptomatic for rickets or osteomalacia and thus
            were considered “normal” for 25(OH)D status. Their study also presented a group
            of  lifeguards  that  had  circulating  25(OH)D  levels  2.5  times  that  of  “normals.”
            Countless similar studies have been performed in the ensuing decades, reiterating
            the same conclusion. I, however, interpret the original Haddad differently; I suggest
            that the 25(OH)D levels in the lifeguards are normal and the Haddad “normals”
            were actually vitamin D deficient. Fortunately, many others now agree with this
            idea and as a result “normal” circulating 25(OH)D levels, from a clinical stand-
            point, are 30–100 ng/mL [2]. Because of this newly defined “normal” range a great
            many patients are deficient in circulating 25(OH)D when tested by their physician.
            As a result, clinical testing of circulating 25(OH)D has literally exploded in the past
            5 years and almost every clinical laboratory wants to perform the test as it is very
            profitable to do so. I will review the methods currently utilized to perform this test-
            ing as well as those for 1,25(OH) D testing.
                                       2

            15.2   Vitamin D Structure and Chemistry


            Vitamin D is a 9,10-seco steroid and exists in two distinct forms: vitamin D  and
                                                                          2
            vitamin D . Vitamin D  is a 28-carbon molecule derived from the plant sterol ergos-
                              2
                    3
            terol, while vitamin D  is a 27-carbon derivative of cholesterol. Vitamin D  differs
                                                                        2
                              3
            from  vitamin  D   in  that  it  contains  an  extra  methyl  group  and  a  double  bond
                         3
            between carbons 22 and 23.
              The most important aspect of vitamin D chemistry centers on its cis-triene struc-
            ture. This unique structure makes vitamin D and related metabolites susceptible to
            oxidation,  ultraviolet  (UV)  light-induced  conformational  changes,  heat-induced
            conformational changes, and attacks by free radicals. Most of these transformation
            Table 15.1  Original assessment of nutritional vitamin D status circa 1971 (From [1])
                                       Weekly consumption   Weekly exposure   Plasma
                              Age      of vitamin D    to sunlight   25(OH)D
            Group         n   year     IU              h             nmol
            Normal volunteers  40  30.2 ± 12.9 2,230 ± 1,041  8.8 ± 6.1  68.3 ± 29.5
            Biliary cirrhosis  4  1.5–55  2,500 (est.)  –            16 ± 6.5*
            Lifeguards      8  18.5 ± 2.0  2,895 ± 677  53.0 ± 10.3  161 ± 21.8*
            Values are means ± SD
            *P < 0.001
   336   337   338   339   340   341   342   343   344   345   346